Available Programs > Online On-Demand

Are you familiar with the role of immunotherapy for non-small cell lung cancer (NSCLC)? In this activity, learners will be immersed in two NSCLC patient cases with interspersed faculty commentary and engaging questions. Upon completion, learners will be better able to select patients with NSCLC who may derive benefit from immunotherapy and recommend immunotherapy according to recent clinical trial data.   Click the link below to access the course: https://learning.freecme.com/a/40555PAURpd6

Are you familiar with the impact of mental health disorders on outcomes for patients with multiple sclerosis (MS)? Join neuropsychiatry expert Jonathan Howard, MD, in this case-based educational activity focused on educating clinicians on the impact of depression and other mental health disorders on patients with MS, identifying opportunities for care collaboration in MS management, and creating patient-specific care strategies for patients with MS to optimize treatment regimens.     Click the link below to access the course: https://cme.healio.com/neurology/ace-the-case/20220923/improving-mental-health-in-patients-with-ms-to-positively-impact-adherence-and-outcomes/overview  

Are you familiar with the role of Janus kinase (JAK) inhibitors for atopic dermatitis (AD)? With over half of patients with AD reporting insufficient disease control, therapeutic management is challenging. In this activity, a dermatology expert explores the rationale behind JAK inhibition for the treatment of AD, clinical trial data on JAK inhibitors for AD, and considering JAK inhibitors when determining patient-specific management of this complex disease.     Click the link below to access the course: https://www.rapidcme.com/activity.aspx?actID=94  

Are you up to date with the role of biomarkers for Alzheimer’s disease (AD)? Biomarkers offer a promising path to early detection of AD, assessing drug efficacy, determining drug appropriateness, and even monitoring disease progression. As AD research continues, it is important for clinicians to stay up to date on current and future uses of biomarkers. In this activity, the association between AD and biomarkers and clinical symptoms of AD will be reviewed, the implementation of validated biomarkers for early…

Are you up to date on the latest guidance for managing menopause-associated vasomotor symptoms (VMS)? This activity will enable you to gain insights from the experts as they identify factors contributing to VMS, discuss approaches to addressing the undertreatment of VMS, review currently available hormonal and nonhormonal treatments for VMS, explore novel targets and nonhormonal investigational agents for treating VMS, and recognize patients who might be appropriate candidates for novel agents for VMS.     Click the link below to…

Looking for the latest evidence from care guidelines and clinical trials in the management of immunoglobulin A nephropathy (IgAN)? Unsure which of the new and merging therapies may be best to consider for your patient with IgAN? In this E-monograph activity, Dr Mohamed Atta will review the important role of proteinuria in IgAN, and the impact of new and emerging therapies for IgAN to optimize proteinuria lowering in clinical practice and improve patient outcomes.  

Are you aware of the strong association between dry eye disease (DED) and meibomian gland dysfunction (MGD)? In this 30-minute educational podcast, Dr Eric D. Donnenfeld offers valuable insights on the association of DED and MGD, as well as the evidence-based protocol for clear and accurate diagnosis, and proper disease management, considering new and emerging therapies for DED and MGD.